Lord, Abbett & Co’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-57,273
| Closed | -$7.11M | – | 899 |
|
2018
Q2 | $7.11M | Buy |
57,273
+3,717
| +7% | +$461K | 0.02% | 679 |
|
2018
Q1 | $5.97M | Sell |
53,556
-142,534
| -73% | -$15.9M | 0.02% | 698 |
|
2017
Q4 | $23.5M | Sell |
196,090
-17,791
| -8% | -$2.13M | 0.07% | 429 |
|
2017
Q3 | $30M | Buy |
+213,881
| New | +$30M | 0.09% | 365 |
|
2016
Q1 | – | Sell |
-229,415
| Closed | -$43.8M | – | 970 |
|
2015
Q4 | $43.8M | Buy |
229,415
+160,287
| +232% | +$30.6M | 0.13% | 241 |
|
2015
Q3 | $10.8M | Sell |
69,128
-23,051
| -25% | -$3.6M | 0.03% | 571 |
|
2015
Q2 | $16.7M | Sell |
92,179
-40,150
| -30% | -$7.26M | 0.04% | 535 |
|
2015
Q1 | $22.9M | Sell |
132,329
-15,830
| -11% | -$2.74M | 0.06% | 450 |
|
2014
Q4 | $27.4M | Buy |
148,159
+87,210
| +143% | +$16.1M | 0.07% | 396 |
|
2014
Q3 | $10.1M | Sell |
60,949
-3,443
| -5% | -$571K | 0.03% | 599 |
|
2014
Q2 | $10.1M | Buy |
+64,392
| New | +$10.1M | 0.02% | 640 |
|
2014
Q1 | – | Sell |
-51,668
| Closed | -$6.88M | – | 1097 |
|
2013
Q4 | $6.88M | Buy |
+51,668
| New | +$6.88M | 0.02% | 755 |
|